Diagenode, a Hologic company, has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetic studies. We offer innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. Our latest innovations include a unique full automation system, the industry's most validated antibodies including Premium antibodies® and Blueprint antibodies™, and the Megaruptor shearing system for long fragment generation in sequencing.
Location: Belgium, Liège, Seraing
Employees: 1001-5000
Phone: +32 4 364 20 50
Total raised: $8.49M
Founded date: 2003
Investors 3
| Date | Name | Website |
| - | Le Groupe ... | sriw.be |
| - | Quest for ... | questforgr... |
| - | Capricorn ... | capricorn.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.06.2016 | - | $8.49M | - |
Mentions in press and media 5
| Date | Title | Description |
| 23.12.2021 | EyeD Pharma raises ⬠32M funding round | Liege, 22 December 2021 - The Liège-based pharmaceutical company, EyeD Pharma, received the backing of Belgian families, entrepreneurs active in the life sciences and public authorities to raise new funds. The €45 million raised will allow ... |
| 07.01.2021 | Diagenode launches innovative solution for small RNA-sequencing compatible with MGI’s DNBSEQ™ sequencers | This powerful solution combines our best-in-class RNA library preparation with MGI’s high-quality, cost-effective, DNA nanoballs sequencing solution, creating a unified platform to support high quality small RNA sequencing. DENVILLE, N.J. a... |
| 16.08.2018 | Diagenode announces acquisition of Service Provider NXT-Dx to complement Epigenetics Assay Services | Denville, USA and Liege, Belgium: 16 August 2018 – Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics servi... |
| 20.06.2016 | Life Sciences Company Diagenode Secures €7.5M | Diagenode, a Liege, Belgium-based life sciences company, secured €7.5m in financing. The capital included an equity component provided by Epimède SA, SRIW SA, OBI SA and the Capricorn Health-tech Fund NV (CHF, Leuven, Belgium) which is mana... |
| 20.06.2016 | Diagenode Raises €7.5M in Financing | Diagenode, a high growth, innovative life sciences company that focuses in epigenetics and molecular diagnostics, announced today that it has secured €7.5 million in financing. The additional capital includes an equity component provided by... |